why choose us

First received: June 06, 2023

Clinical Trial: Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cutaneous Melanoma

Study Type: INTERVENTIONAL


Official Title: Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Brief Summary: The purpose of this pilot study will be to provide i) information on feasibility implementing an exercise intervention trial among patients with cutaneous cancers, including melanoma, squamous cell carcinoma (cuSCC), and Merkel cell carcinoma, scheduled to receive checkpoint blockade immunotherapy, and ii) preliminary data on the impact of a day-of-therapy exercise intervention.

Read more